RBEIMPT

Tae Kyu Lee1, Wen C Hsi2

  • 1Department of Radiation Oncology, Allina Health, Minneapolis, MN, USA; Department of Radiation Oncology, Indiana University Health Arnett, Lafayette, IN, USA.

概括

在质子疗法中,可变的相对生物有效性 (RBE) 增加了风险器官的正常组织并发症概率 (NTCPs),这表明在治疗规划中必须考虑RBE变化.